Radiologist Engagement as a Potential Barrier to the Clinical Translation of Quantitative Imaging for the Assessment of Tumor Heterogeneity

Published:February 02, 2018DOI:

      Rationale and Objective

      This study aims to identify potential barriers to the clinical implementation of quantitative imaging for the assessment of tumor heterogeneity.

      Materials and Methods

      An 18-month prospective observational study was undertaken in which the clinical implementation of computed tomography texture analysis (CTTA) as a technique for quantifying tumor heterogeneity in patients with non–small cell lung cancer was assessed using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.


      Adopters of the technology comprised five specialists with dual accreditation in radiology and nuclear medicine supervising two trainees. Tumor heterogeneity information was extracted and reported in 190 of 322 eligible cases (59%) and presented at the multidisciplinary team meeting in 124 of 152 patients (82%) for whom CTTA had been performed. The maximum proportion of eligible cases in which heterogeneity information had been extracted and reported in any quarter was 80%, but fell in the latter half of the study. The maximum frequency with which available CTTA results were presented at the multidisciplinary team meeting in any quarter was 92% and was maintained in the latter part of the study. Significant differences in survival were observed for patients categorized using the two reported CTTA values (P = 0.004 and P = 0.0057, respectively).


      Radiologist engagement is a potential barrier to the effective translation of quantitative imaging assessments of tumor heterogeneity into clinical practice and will need to be addressed before tumor heterogeneity information can successfully contribute to clinical decision making in oncology.

      Key Words

      Abbreviations and Acronyms:

      CT (computed tomography), CTTA (computed tomography texture analysis), MDT (multidisciplinary team), NSCLC (non–small cell lung cancer), PACS (picture archiving and communicating systems), PET (positron emission tomography), RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Burrell R.A.
        • McGranahan N.
        • Bartek J.
        • et al.
        The causes and consequences of genetic heterogeneity in cancer evolution.
        Nature. 2013; 501 (e45): 338
        • Davnall F.
        • Yip C.S.P.
        • Ljungqvist G.
        • et al.
        Assessment of tumor heterogeneity: an emerging imaging technique for clinical practice?.
        Insights Imaging. 2012; 3: 573-589
        • O'Connor J.P.B.
        • Rose C.J.
        • Waterton J.C.
        • et al.
        Imaging intratumor heterogeneity: role in therapy response, resistance and clinical outcome.
        Clin Cancer Res. 2015; 21: 249-257
        • Bashir U.
        • Siddique M.M.
        • McLean E.
        • et al.
        Imaging heterogeneity in lung cancer: techniques, applications and challenges.
        AJR Am J Radiol Roentgenol. 2016; 207: 534-543
        • Cox V.L.
        • Bhosale P.
        • Varadhachary G.R.
        • et al.
        Cancer genomics and important oncologic mutations: a contemporary guide for body imagers.
        Radiology. 2017; 283: 314-340
        • Weiss G.J.
        • Ganeshan B.
        • Miles K.A.
        • et al.
        Non-invasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.
        PLoS ONE. 2014; 9 (e100244)
        • Caramella C.
        • Bluthgen M.V.
        • Rosellini S.
        • et al.
        Prognostic value of texture analysis and correlation with molecular profile in EGFR mutated/ALK rearranged advanced non-small cell lung cancer (NSCLC).
        Europ J Cancer. 2015; 51: S647-S648
        • Craigie M.
        • Squires J.
        • Miles K.
        Can CT measures of tumour heterogeneity stratify risk for nodal metastasis in patients with non-small cell lung cancer?.
        Clin Radiol. 2017; 72: 899.e1-899.e7
        • Win T.
        • Miles K.A.
        • Janes S.M.
        • et al.
        Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer.
        Clin Cancer Res. 2013; 19: 3591-3599
        • Fried D.V.
        • Tucker S.L.
        • Zhou S.
        • et al.
        Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.
        Int J Radiat Oncol Biol Phys. 2014; 90: 834-842
        • Bluthgen M.V.
        • Caramella C.
        • Faire L.
        • et al.
        Prognostic value of texture analysis in advanced non-small cell lung cancer (NSCLC).
        Europ J Cancer. 2015; 51: S645-S646
        • Chowdhury R.
        • Ganeshan B.
        • Irshad S.
        • et al.
        The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.
        Br J Radiol. 2014; 8: 20140065
        • Lee C.I.
        • Gupta S.
        • Sherry S.J.
        • et al.
        Translating new imaging technologies to clinical practice.
        Acad Radiol. 2018; 25 (Epub ahead of print 2017 August 31): 3-8
        • Bakken S.
        • Ruland C.M.
        Translating clinical informatics interventions into routine clinical care: how can the RE-AIM framework help?.
        J Am Med Inform Assoc. 2009; 16: 889-897
        • Miles K.A.
        • Ganeshan B.
        • Hayball M.P.
        CT texture analysis using the filtration-histogram method: what do the measurements mean?.
        Cancer Imaging. 2013; 13: 400
        • Miles K.A.
        How to use CT texture analysis for prognostication of non-small cell lung cancer.
        Cancer Imaging. 2016; 16: 10